DICHLOROMETHOTREXATE - A CRITICAL REASSESSMENT

被引:6
作者
ODWYER, PJ
LEYLANDJONES, B
ALONSO, MT
EISENBERGER, M
HOTH, DF
机构
关键词
D O I
10.1200/JCO.1985.3.8.1148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1148 / 1153
页数:6
相关论文
共 33 条
[1]  
ADAMSON RH, 1962, P SOC EXP BIOL MED, V111, P566
[2]  
BAND PR, 1973, CANCER CHEMOTH REP 1, V57, P79
[3]  
CLEVELAND JC, 1969, CURRENT TOPICS SURGE, P113
[4]   PHARMACOLOGIC RATIONALE FOR REGIONAL DRUG DELIVERY [J].
COLLINS, JM .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :498-504
[5]  
DAVIDSON JD, 1965, CLIN PHARMACOL THER, V6, P321
[6]  
ENSMINGER W, 1981, P AM ASSOC CANC RES, V22, P271
[7]  
FERNBACH B, 1979, RECENT RESULTS CANCE, V74, P56
[8]   COLLATERAL SENSITIVITY BETWEEN METHYLENE DIMETHANE SULFONATE AND HALOGENATED METHOTREXATE DERIVATIVES IN YOSHIDA SARCOMA INVIVO AND INVITRO [J].
FOX, BW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (04) :955-958
[9]  
FREI E, 1965, CLIN PHARMACOL THER, V6, P160
[10]  
GOLDIN A, 1959, J NATL CANCER I, V22, P811